Ranolazine is associated with a reduced incidence of atrial fibrillation in patients with chronic coronary syndrome: the results of a real-world analysis of an Italian population

25 August 2023 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: The role of rate control and comorbidities in atrial fibrillation Rhythm Control, Antiarrhythmic Drugs ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology